Moderna, Merck melanoma vaccine clears Phase 3 trial goal
What's next: The companies plan talks with regulators within months as they pursue approval for the personalized shot with Keytruda.
What's next: The companies plan talks with regulators within months as they pursue approval for the personalized shot with Keytruda.
Why it matters: Bemotrizinol, already used in Europe and Asia, blocks UVA and UVB rays and could expand lighter-feeling sunscreen options in the US.